menu
    • menu

    Company profile for F-star Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies with the goal of creating a paradigm-shift in cancer therapy. F-star is a biopharmaceutical company focused on developing immuno-oncology bispecific antibody therapeutics. We are committed to delivering life-changing treatments to those patients with cancer who are not well-served by current therapies through the application of o...
    F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies with the goal of creating a paradigm-shift in cancer therapy. F-star is a biopharmaceutical company focused on developing immuno-oncology bispecific antibody therapeutics. We are committed to delivering life-changing treatments to those patients with cancer who are not well-served by current therapies through the application of our Modular Antibody Technology™ platform. We believe our platform enables the discovery of novel bispecific antibodies, which are selected for their potential to transform the treatment of cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    F-star Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Eddeva B920 Babraham Research Campus Cambridge, CB22 3AT
    Telephone
    Telephone
    +44-1223-497400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://f-star.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    F-star splits from invoX after $161M acquisition in 2023
    F-star splits from invoX after $161M acquisition in 2023

    07 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/f-star-charts-new-path-splitting-invox-after-2023s-161m-acquisition

    FIERCE BIOTECH
    07 Apr 2025
    Share Share
    F-star bags Takeda tie-up in a year with multi-specific antibodies for cancer
    F-star bags Takeda tie-up in a year with multi-specific antibodies for cancer

    06 Jul 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/f-star-bags-third-takeda-tie-up-in-a-year-with-multi-specific-antibodies-for-cancer/

    Kyle LaHucik ENDPTS
    06 Jul 2023
    Share Share
    invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
    invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.

    08 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230308005755/en

    BUSINESSWIRE
    08 Mar 2023
    Share Share
    F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX
    F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX

    07 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/07/2622160/0/en/F-star-Therapeutics-Announces-CFIUS-Clearance-for-Proposed-Acquisition-by-invoX-Pharma.html

    GLOBENEWSWIRE
    07 Mar 2023
    Share Share
    F-star's sale to Chinese buyer cleared by CFIUS following months of holdup
    F-star's sale to Chinese buyer cleared by CFIUS following months of holdup

    07 Mar 2023

    // Amber Tong ENDPTS

    https://endpts.com/f-stars-sale-to-chinese-buyer-cleared-by-cfius-following-months-of-holdup/

    Amber Tong ENDPTS
    07 Mar 2023
    Share Share
    F-star Therapeutics Stock Jumps on Extension to Invox Pharma Merger Deadline
    F-star Therapeutics Stock Jumps on Extension to Invox Pharma Merger Deadline

    01 Feb 2023

    // MARKETWATCH

    https://www.marketwatch.com/story/f-star-therapeutics-stock-jumps-on-extension-to-invox-pharma-merger-deadline-271675271722?mod=markets

    MARKETWATCH
    01 Feb 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search